A Phase 2 Study of CRD-4730 in CPVT | MicrobiomeTrials← Back to trialsNCT06658899
A Phase 2 Study of CRD-4730 in CPVT
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-12-01Est. Completion: 2027-04
Enrollment target: 12 participants Locations- Cardurion Investigative Site, San Francisco, California, United States
- Cardurion Investigative Site, Morrisville, North Carolina, United States
- Cardurion Investigative Site, Houston, Texas, United States
- Cardurion Investigative Site, Salt Lake City, Utah, United States
- Cardurion Investigative Site, Madison, Wisconsin, United States
- Cardurion Investigative Site, Vancouver, British Columbia, Canada
- Cardurion Investigative Site, Bron, France
- Cardurion Investigative Site, Paris, France
- Cardurion Investigative Site, Saint-Herblain, France
- Cardurion Investigative Site, Pavia, Pavia, Italy
- Cardurion Investigative Site, Amsterdam, North Holland, Netherlands
- Cardurion Investigative Site, Esplugues de Llobregat, Barcelona, Spain
Other microbiome trials you might be interested in
Catecholaminergic Polymorphic Ventricular Tachycardia
This is a Phase 1b, Multicenter, Open-Label, Dose Finding Study to Investigate the Safety and Tolerability of a Single I…
Boston, United StatesEst. completion Jun 2027
Long QT SyndromeCatecholaminergic Polymorphic Ventricular Tachycardia Type 1Catecholaminergic Polymorphic Ventricular Tachycardia Type 2
The goal of this observational study is to evaluate exercise testing and daily physical activity in children and adolesc…
London, United KingdomCompleted May 31, 2026
Cardurion